Airsculpt Technologies Inc
For the period ended Dec 31, 2023. Filed Feb 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 27, 2024
AIRS$0.77+14.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
| Twelve Months EndedDecember 31, | |||
|---|---|---|---|
| ($000s) | 2023 | 2022 | 2021 |
| Cash flows from operating activities | |||
| Net (loss)/income | $(4,479) | $(14,679) | $10,551 |
| Adjustments to reconcile net (loss)/income to net cash provided by operating activities: | |||
| Depreciation and amortization | 10,253 | 8,061 | 6,597 |
| Equity-based compensation | 18,224 | 29,457 | 7,185 |
| Non-cash interest expense; amortization of debt costs | 207 | 921 | 639 |
| Loss on debt modification | — | 932 | 682 |
| Deferred income taxes | 1,342 | 1,134 | 208 |
| (Gain)/loss on disposal of long-lived assets | (212) | 147 | — |
| Changes in assets and liabilities | |||
| Taxes receivable | 890 | (2,831) | — |
| Prepaid expense and other current assets | 466 | (5) | (3,845) |
| Other assets | (3,814) | (7,274) | (1,305) |
| Accounts payable | (206) | 865 | 1,576 |
| Deferred revenue and patient deposits | (896) | (452) | (423) |
| Accrued and other liabilities | 2,181 | 8,171 | 4,768 |
| Net cash provided by operating activities | 23,956 | 24,447 | 26,633 |
| Cash flows from investing activities | |||
| Purchases of property and equipment, net | (9,919) | (12,921) | (7,116) |
| Net cash used in investing activities | (9,919) | (12,921) | (7,116) |
| Cash flows from financing activities | |||
| Payment on term loan | (12,125) | (84,263) | (838) |
| Borrowings on term loan, net | — | 83,503 | 49,603 |
| Proceeds from IPO | — | — | 13,542 |
| Distribution to member | (79) | (1,159) | (66,856) |
| Dividends paid to shareholders | (385) | (23,160) | — |
| Payment of taxes withheld through vested equity-based compensation | (233) | (2,031) | — |
| Other financing activity | (569) | (147) | — |
| Net cash used in financing activities | (13,391) | (27,257) | (4,549) |
| Net decrease in cash and cash equivalents | 646 | (15,731) | 14,968 |
| Cash and cash equivalents | |||
| Beginning of period | 9,616 | 25,347 | 10,379 |
| End of period | $10,262 | $9,616 | $25,347 |
| Supplemental disclosure of cash flow information: | |||
| Cash paid for interest | $6,277 | $5,830 | $4,255 |
| Cash paid for taxes | $4,663 | $4,932 | $— |
| Supplemental disclosure of non-cash investing information: | |||
| Property and equipment included in accounts payable and accrued expenses | $283 | $1,113 | $255 |
| Distributions to member included in accrued expenses | $— | $— | $427 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.